Investor FAQs

Show All
What does Lisata Therapeutics do?

Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Lisata’s lead investigational product candidate, LSTA1 (formerly known as CEND-1), is designed to modify the tumor microenvironment by activating a novel uptake pathway that allows anti-cancer drugs to penetrate solid tumors more effectively. LSTA1 actuates an active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are not affected. LSTA1 has demonstrated favorable safety, tolerability, and activity in clinical trials to enhance delivery of standard-of-care chemotherapy for pancreatic cancer. Lisata and its collaborators have also amassed significant non-clinical data demonstrating enhanced delivery of a range of emerging anti-cancer therapies, including immunotherapies and RNA-based therapeutics. Lisata is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors more effectively. In addition, Lisata also has clinical development programs based on its autologous CD34+ cell therapy technology platform.

How many employees does Lisata have?
As of September 22, 2022, the Company has 29 full-time employees.
Where can I find Lisata’s latest investor presentation?
The most recent investor presentation is available under the Investors & News section.
What is Lisata’s exchange, ticker symbol and CUSIP?
Exchange: Nasdaq
Ticker Symbol: LSTA
CUSIP: 128058302
When does Lisata’s fiscal year end?
Lisata’s fiscal year ends on December 31.
Where are Lisata’s headquarters?
110 Allen Road
Second Floor
Basking Ridge, NJ 07920 

Tel: (908) 842-0100
Who is Lisata’s IR contact?
John D. Menditto
Vice President
Investor Relations & Corporate Communications
Phone: +1-908-842-0084
Email: jmenditto@lisata.com
 
What is Lisata’s Financial Conflict of Interest Policy?
You can view the Company’s Financial Conflict of Interest Policy by visiting the Financial Conflict of Interest Policy Statement page.
Who are the Lisata’s auditor and corporate legal counsel?
The Company’s auditor is Grant Thornton LLP auditor is Grant Thornton LLP (www.granthornton.com).

The Company’s corporate legal counsel is Mintz Levin Cohn Ferris Glovsky and Popeo PC (www.mintz.com).
Who is Lisata’s transfer agent?
The Company’s transfer agent is American Stock Transfer & Trust Company (AST) (www.astfinancial.com).

Telephone and email assistance
You may reach an AST representative by dialing (1-800) 937-5449 or by dialing (718) 921-8124. You can also e-mail AST at help@astfinancial.com.
Customer service representatives are available 8 a.m. to 8 p.m. Eastern Time, Monday through Friday.

Mail inquiries:
To contact AST via postal mail:
Lisata Therapeutics, Inc.
c/o AST
6201 15th Avenue
Brooklyn, NY 11219
Who do I contact about replacement of stock certificates?
To replace lost stock certificates, please contact the Company’s transfer agent.
Who should shareholders notify of a change in address?
To change your address, please contact the Company’s transfer agent.
What financial analysts cover Lisata?
Please refer to the Analyst Coverage section.
Can I buy Lisata Therapeutics stock directly from the company?
Lisata does not offer a direct stock purchase plan. Shares of the company can be purchased through a brokerage company.
Does Lisata issue dividends on its common stock?
Lisata has never declared or paid cash dividends. The Company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.
When is Lisata’s Annual Meeting of Stockholders?
Specific information about this year’s Annual Shareholder Meeting can be found in this year’s proxy statement available under SEC Filings.
What should I do if I have a question that is not answered here?
Please submit your question using the form under Contact Us.
I OWN SHARES OF THE COMPANY’S STOCK – AM I A STOCKHOLDER OF RECORD OR A BENEFICIAL OWNER?

If your shares are registered directly in your name with the Company’s registrar and transfer agent, American Stock Transfer & Trust Company, LLC, you are considered a stockholder of record with respect to those shares. If your shares are held in a brokerage account or bank, trust, or other nominee, you are considered the “beneficial owner” of those shares.

I AM A STOCKHOLDER OF RECORD AND HAVE QUESTIONS ABOUT MY STOCK OWNERSHIP. WHO SHOULD I CONTACT?

If you are a stockholder of record, your record holder account is registered at American Stock Transfer & Trust Company, LLC (“AST”), our registrar and transfer agent.

You may contact AST by phone, by visiting their website or by mail with specific questions about your stock ownership:

Telephone and email assistance:

You may reach an AST representative by dialing (1-800) 937-5449 or by dialing (718) 921-8124. You can also e-mail AST at help@astfinancial.com.

Customer service representatives are available 8 a.m. to 8 p.m. Eastern Time, Monday through Friday.

Mail inquiries:

To contact AST via postal mail:

Lisata Therapeutics, Inc.

c/o AST

6201 15th Avenue

Brooklyn, NY 11219

Be sure to keep your account at AST current. Abandoned property laws in the United States require you to keep your account information current to avoid shares and/or funds from being turned over to the state of your last known residence. Lisata Therapeutics, Inc. is required to follow these abandoned property regulations. Even if you haven’t moved and your statements are delivered quarterly, according to some states, your account could be deemed abandoned if you have not accessed your account or contacted AST within three years.

To avoid your account being deemed abandoned or lost:

Keep your account current. Access your account on-line or vote your proxy. Ensure that AST has your correct address on file. You can change your mailing address at any time by logging on to your online account at https://www.astfinancial.com/. Please note, if you reside outside the U.S., your shares and/or funds would be turned over to Delaware, our state of incorporation.

If your shares are turned over to the state, it will be necessary to contact the state directly and file a claim, which can be a lengthy process.

I AM A BENEFICIAL OWNER AND HAVE QUESTIONS ABOUT MY STOCK OWNERSHIP. WHO SHOULD I CONTACT?

If you are a beneficial owner of shares (e.g., you own shares through a bank or brokerage account) and have specific questions about your stock ownership, it will be necessary to contact your bank/broker directly for assistance.